Book An Appointment

BookAppointment

Education

  • MBBS - Dr. P.D.M. Medical College, Amaravati University, Maharashtra (1992-1997)
  • MD (Internal Medicine) - Jawaharlal Nehru Medical College, Rajiv Gandhi University, Belgaum, Karnataka (1999-2002)
  • DNB (Nephrology) - Kamineni Hospitals, Hyderabad, Andhra Pradesh (2004-2007)
  • MNAMS (Member of National Academy of Medical Sciences, India)

Past Positions

  • Nephrology Fellow at University of California at San Diego, California (Oct-Nov 2009)
  • Nephrology fellow at V U Medical Center, Amsterdam, Netherlands, Academic Exchange Program (March 2011)
  • Registrar in Nephrology at Kamineni Hospitals, Hyderabad (2004-2007)
  • Medical Registrar in Acute Medical Care Unit at Yashoda Hospitals, Hyderabad. (Jan 2003 to Oct 2003)

Skills/Expertise

  • Hands on experience in procedures like percutaneous CAPD (Tenckhoff) catheterization, percutaneous renal biopsy, both temporary and permanent tunneled hemodialysis catheter insertions.
  • Good experience in all areas of renal replacement therapy including Intermittent Hemodialysis, SLED, CRRT, CAPD, APD, Plasmapheresis and Haemoperfusion therapies.
  • Well versed with various immunosuppression protocols in renal transplantation.
  • Basic GCP workshop training by Quintiles (April 2011)

Publications

  • Vikranth Reddy, Rajasekara Chakravarthi, Shahista Hussani, Hari Krishna Marri, Guri S.B. Palabukkala “Is Induction a Necessary Strategy for Renal Transplantation”. Transplantatiion journal 2008; 86: Vol - 86, 2S.
  • Vikranth Reddy, S. Samavedam, R. Chakravarthi, Hari Krishna, Mallikarjun. Is the profile of AKI needing intensive care changes in developing countries? Blood purification 2009; 27: 271- 305
  • Vikranth Reddy, Hari Krishna, R. Chakravarthi, . S. Hussaini. Citrate anticoagulation in CRRT. Blood purification 2010.
  • “An open label, multi-center study to evaluate the efficacy, tolerability and safety of Darbepoetin Alfa in patients of anemia associated with chronic kidney disease (CKD)Vikranth Reddysubmitted for publication Indian Journal of Nephrology (2017-18)
  • Vikranth Reddy,3 Prabir Roy-Chaudhury,4 Suresh Chandra Tiwari,5 James A. Tumlin,6 Don E. Williamson.7 1Harvard U; 2U of Texas; 3Care Hospital, Hyderabad, India; 4U of Cincinnati; 5Fortis Inst, New Delhi, India; 6U of Tennessee; 7Nephrology Associates, Augusta, GA. Greater Frequency of Clinically Significant Bradycardia Than Ventricular Tachycardia in Hemodialysis Patients: Preliminary Results of the Monitoring in Dialysis (MiD) Study. .J Am SocNephrol 25: 2014.

Research Presentation

  • Pesentations:
    1). “Infections in Hemodialysis unit – Our experience”, at SCISN-2005, Southern Chapter – Indian Society of Nephrology Annual meet at Chennai (February 2005)
  • “Post-transplant Acute pancreatitis – Treatment & Outcome” at WCN 2007, World Congress of Nephrology 2007 at Rio de Janeiro, Brazil (April 2007)
  • “Is induction a necessary strategy for renal transplantation?” Transplantation July 27, 2008
  • “Role of CAPD in refractory CHF – single center experience” (ISN & ISPD 2009, presented at Annual conference of PDSI in Goa, Sept 2009.
  • “Icodextrin-Effects on residual kidney function” (ISN-WZ 2009) presented at Annual Conference of peritoneal dialysis, Society of India in Goa, Sept 2009
  • “Strategies for the use of PSI’s in transplantation” Guest lecture given at XX Annual conference of Indian Society of Organ Transplantation (ISOT) at Varanasi Oct 2009.
  • “PD in AKI”, presented at 16th Annual Conference of Indian Society of Critical Care Medicine & International Critical Care congress (10th -14th Feb’10, Hyderabad)
  • “RRT in ICU” presented in 15th International Conference on CRRT at San Diego, Feb 2010.
  • Research:
    An open labeled prospective multicentric study of Lanthanum Carbonate in combination with calcium based phosphate binders in patients of hyperphosphatemia of Chronic Kidney Disease
  • An open label, multi-Centre, prospective study to demonstrate safety and efficacy of once daily Advagraf in patients undergoing kidney or liver transplantation in India.
  • “An open label, multi-center study to evaluate the efficacy, tolerability and safety of Darbepoetin Alfa in patients of anemia associated with chronic kidney disease (CKD).
  • “A post marketing surveillance study evaluating the safety and tolerability of the labelled use of Hetero-Darbepoetin Alfa in Indian patients.

Memberships

  • Indian Medical Council – Telangana State Medical Council
  • Member-International Society of Nephrology (ISN)
  • Life Member of Indian Society of Nephrology (ISN)
  • Life Member of Indian Academy of Nephrology (IAN)
  • Life Member of Peritoneal Dialysis Society of India (PDSI)
  • Life Member of Association of Physicians of India (API)
  • Life Member of Research Society for the Study of Diabetes in India (RSSDI)
  • Member of National Academy of Medical Sciences, India (MNAMS)
  • Life Member of Indian Society of Nephrology-Southern Chapter (ISNSC)
  • Member of European Renal Association (ERA-EDTA)
  • Member of Indian Society of Organ Transplantation. (ISOT)
  • Member of American Society of Nephrology (ASN)
  • Executive member of Hyderabad Nephrology Forum.

Award and Recognition

  • Swamy Vivekananda Vishista Puraskaralu-2014 award received on 11th January, 2014 at Ravindra Bharathi, Hyderabad.
  • Best Paper Award for “Infections in Hemodialysis unit – Our experience”, at SCISN-2005, Southern Chapter – Indian Society of Nephrology Annual meet at Chennai (February 2005)
  • “Ugadi Excellency Awards”2018, award received on 15th March 2018 at Ravindra Bharathi, Hyderabad.
  • Vaidya Siromani Award 2018, award Vignana Kendra on the occasion of doctors day (1st July 2018).